Cargando…

Molecular Modelling Study and Antibacterial Evaluation of Diphenylmethane Derivatives as Potential FabI Inhibitors

The need for new antibiotics has become a major worldwide challenge as bacterial strains keep developing resistance to the existing drugs at an alarming rate. Enoyl-acyl carrier protein reductases (FabI) play a crucial role in lipids and fatty acid biosynthesis, which are essential for the integrity...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hasan, Shaima, Kayed, Kawthar, Ghemrawi, Rose, Bataineh, Nezar Al, Mahgoub, Radwa E., Audeh, Rola, Aldulaymi, Raghad, Atatreh, Noor, Ghattas, Mohammad A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095751/ https://www.ncbi.nlm.nih.gov/pubmed/37049763 http://dx.doi.org/10.3390/molecules28073000

Ejemplares similares

The Discovery of Potent SHP2 Inhibitors with Anti-Proliferative Activity in Breast Cancer Cell Lines
por: Ghemrawi, Rose, et al.
Publicado: (2022)

Mutations upstream of fabI in triclosan resistant Staphylococcus aureus strains are associated with elevated fabI gene expression
por: Grandgirard, Denis, et al.
Publicado: (2015)

Nonactive-Site Mutations in S. aureus FabI That Induce Triclosan Resistance
por: Demissie, Robel, et al.
Publicado: (2020)

Implementation of permeation rules leads to a FabI inhibitor with activity against Gram-negative pathogens
por: Parker, Erica N., et al.
Publicado: (2019)

Mobile Phones: Reservoirs of Resistant Bacteria during the COVID-19 Pandemic in Abu Dhabi, United Arab Emirates
por: Kayed, Kawthar, et al.
Publicado: (2023)

Staphylococcus aureus but not Listeria monocytogenes adapt to triclosan and adaptation correlates with increased fabI expression and agr deficiency
por: Nielsen, Lene Nørby, et al.
Publicado: (2013)

Meleagrin, a New FabI Inhibitor from Penicillium chryosogenum with at Least One Additional Mode of Action
por: Zheng, Chang Ji, et al.
Publicado: (2013)

Pharmacophore and Molecular Docking Guided 3D-QSAR Study of Bacterial Enoyl-ACP Reductase (FabI) Inhibitors
por: Lu, Xiaoyun, et al.
Publicado: (2012)

Correlating drug–target kinetics and in vivo pharmacodynamics: long residence time inhibitors of the FabI enoyl-ACP reductase
por: Daryaee, Fereidoon, et al.
Publicado: (2016)

Drug-likeness prediction of designed analogues of isoniazid standard targeting FabI enzyme regulation from P. falciparum
por: Pandey, Anil Kumar, et al.
Publicado: (2019)

Pharmacokinetics, pharmacodynamics and efficacy of novel FabI inhibitor AFN-1252 against MSSA and MRSA in the murine thigh infection model
por: Banevicius, Mary A, et al.
Publicado: (2013)

DNA and protein methyltransferases inhibition by adenosine dialdehyde reduces the proliferation and migration of breast and lung cancer cells by downregulating autophagy
por: Ghemrawi, Rose, et al.
Publicado: (2023)

Activity of AFN-1252, a novel FabI inhibitor, against Staphylococcus aureus in an in vitro pharmacodynamic model simulating human pharmacokinetics
por: Tsuji, Brian T, et al.
Publicado: (2013)

In vitro activity (MICs and rate of kill) of AFN-1252, a novel FabI inhibitor, in the presence of serum and in combination with other antibiotics
por: Kaplan, Nachum, et al.
Publicado: (2013)

Ligand‐ and Structure‐Based Approaches of Escherichia coli FabI Inhibition by Triclosan Derivatives: From Chemical Similarity to Protein Dynamics Influence
por: Kronenberger, Thales, et al.
Publicado: (2019)

The Discovery of Small Allosteric and Active Site Inhibitors of the SARS-CoV-2 Main Protease via Structure-Based Virtual Screening and Biological Evaluation
por: Mahgoub, Radwa E., et al.
Publicado: (2022)

Allosteric Binding Sites of the SARS-CoV-2 Main Protease: Potential Targets for Broad-Spectrum Anti-Coronavirus Agents
por: Alzyoud, Lara, et al.
Publicado: (2022)

An Iterative Approach Guides Discovery of the FabI Inhibitor Fabimycin, a Late-Stage Antibiotic Candidate with In Vivo Efficacy against Drug-Resistant Gram-Negative Infections
por: Parker, Erica N., et al.
Publicado: (2022)

Correction to “An Iterative Approach Guides Discovery of the FabI Inhibitor Fabimycin, a Late-Stage Antibiotic Candidate with In Vivo Efficacy against Drug-Resistant Gram-Negative Infections”
por: Parker, Erica N., et al.
Publicado: (2022)

Sensitization and cross‐reactivity patterns of contact allergy to diisocyanates and corresponding amines: investigation of diphenylmethane‐4,4′‐diisocyanate, diphenylmethane‐4,4′‐diamine, dicyclohexylmethane‐4,4′‐diisocyanate, and dicylohexylmethane‐4,4′‐diamine
por: Hamada, Haneen, et al.
Publicado: (2017)

Identified Seaweed Compound Diphenylmethane Serves as an Efflux Pump Inhibitor in Drug-Resistant Escherichia coli
por: Lu, Wen-Jung, et al.
Publicado: (2021)

Druggability analysis and classification of protein tyrosine phosphatase active sites
por: Ghattas, Mohammad A, et al.
Publicado: (2016)

Influence of Lignin and Polymeric Diphenylmethane Diisocyante Addition on the Properties of Poly(butylene succinate)/Wood Flour Composite
por: Park, Chan-Woo, et al.
Publicado: (2019)

Interpretation of the mechanism of 3,3′-dichloro-4,4′-diamino diphenylmethane synthesis over HY zeolites
por: Ruan, Xiao, et al.
Publicado: (2020)

Nanocomposites of Rigid Polyurethane Foam and Graphene Nanoplates Obtained by Exfoliation of Natural Graphite in Polymeric 4,4′-Diphenylmethane Diisocyanate
por: Shin, Se-Ra, et al.
Publicado: (2022)

The Influence of Diisocyanate Structure on Thermal Stability of Thermoplastic Polyurethane Elastomers Based on Diphenylmethane-Derivative Chain Extender with Sulfur Atoms
por: Rogulska, Magdalena
Publicado: (2023)

Structure-based assessment and druggability classification of protein–protein interaction sites
por: Alzyoud, Lara, et al.
Publicado: (2022)

Identification of new inhibitors of Mdm2–p53 interaction via pharmacophore and structure-based virtual screening
por: Atatreh, Noor, et al.
Publicado: (2018)

Discovery of new butyrylcholinesterase inhibitors via structure-based virtual screening
por: Atatreh, Noor, et al.
Publicado: (2019)

Single chain Fab (scFab) fragment
por: Hust, Michael, et al.
Publicado: (2007)

Controlled Release of Pyrimidine Compound Using Polymeric Coated ZIF-8 Metal-Organic Framework as Glucagon-Like Peptide-1 Receptor Agonist Carrier
por: AlNeyadi, Shaikha S., et al.
Publicado: (2020)

An assessment of the current practice of community pharmacists for the disposal of medication waste in the United Arab Emirates: A deep analysis at a glance
por: Kharaba, Zelal, et al.
Publicado: (2022)

Production of single chain Fab (scFab) fragments in Bacillus megaterium
por: Jordan, Eva, et al.
Publicado: (2007)

"Estudio morfométrico simplificado (Fabis I) de las abejas Apis mellífera L de la región de Misantla, Veracruz" /
por: Roa Gallardo, Hugo
Publicado: (1989)

DutaFabs are engineered therapeutic Fab fragments that can bind two targets simultaneously
por: Beckmann, Roland, et al.
Publicado: (2021)

Endoplasmic Reticulum Stress and Unfolded Protein Response in Neurodegenerative Diseases
por: Ghemrawi, Rose, et al.
Publicado: (2020)

Fab : the coming revolution on your desktop--from personal computers to personal fabrication
por: Gershenfeld, Neil A.
Publicado: (2005)

Functions of the Clostridium acetobutylicium FabF and FabZ proteins in unsaturated fatty acid biosynthesis
por: Zhu, Lei, et al.
Publicado: (2009)

FabR regulates Salmonella biofilm formation via its direct target FabB
por: Hermans, Kim, et al.
Publicado: (2016)

Self-fab house : 2nd Advanced Architecture Contest /
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_4loh7l5bic7r22944sk1c7q4c6